Golec, Joseph; Vernon, John A. - In: PharmacoEconomics 28 (2010) 8, pp. 615-628
EU countries closely regulate pharmaceutical prices, whereas the US does not. This paper shows how price constraints affect the profitability, stock returns and R&D spending of EU and US firms. Compared with EU firms, US firms are more profitable, earn higher stock returns and spend more on R&D....